Clinical Trial Update: Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

View source ↗

Summary

A clinical trial evaluated Symbicort Turbuhaler for use as both maintenance and reliever therapy in bronchial asthma, and the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchial Asthma

Drugs mentioned

• Symbicort Turbuhaler (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Bronchial Asthma | Status: COMPLETED